Term ends Jun 7, 2037 · Medium confidence
20-year base term ends Jun 7, 2037
Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 11,819,496), so the cap could be lower.
Jun 7, 2017
Jun 7, 2037
Jun 11, 2024
This patent's term runs 228 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 0 of 3 maintenance fees are paid so far. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jun 7, 2017, when application 15/616,409, the earliest non-provisional in its chain, was filed (this one was filed Aug 13, 2021) | Jun 7, 2037 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +228 days, USPTO patent term adjustment record | Jan 21, 2038 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 11,129,818, US 11,819,496) | capped to Jun 7, 2037 | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jun 7, 2037 | Medium confidence |
This family
| US 9,895,359 | In force Jun 2037 | Jun 2037 |
| US 9,907,788 | In force Jun 2037 | Jun 2037 |
| US 9,884,050 | In force Jun 2037 | Jun 2037 |
| US 11,534,493 | In force Jun 2037 | Jun 2037 |
| US 10,172,841 | In force Jun 2037 | Jun 2037 |
| US 10,105,354 | In force Jun 2037 | Jun 2037 |
| US 10,940,142 | In force Jun 2037 | Jun 2037 |
| Application 62/768,314 | Provisional application no patent term | no patent term |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Dec 22, 2021 Reel 58463, frame 187 | Arcutis Biotherapeutics, Inc. | SLR Investment Corp., as Agent | Security Interest |
| Mar 19, 2024 Reel 66821, frame 809 | Arcutis, Inc. | Arcutis Biotherapeutics, Inc. | Change of Name |
| Mar 19, 2024 Reel 66821, frame 437 | Osborne, David W. | Arcutis, Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 11,129,818, US 11,819,496.